Literature DB >> 3126675

Hemophilia-associated AIDS in the United States, 1981 to September 1987.

J K Stehr-Green1, R C Holman, J M Jason, B L Evatt.   

Abstract

Between January 1, 1981 and September 4, 1987, 407 cases of hemophilia-associated acquired immunodeficiency syndrome (AIDS) had been reported to the Centers for Disease Control. The number of cases diagnosed each year nearly doubled, except in 1986, when cases increased only 50 per cent. Demographic characteristics of the patients did not change over time. The majority (74 per cent) had severe hemophilia and 97 per cent received commercially produced concentrated clotting factors. The cumulative incidence of AIDS between 1981 and September 1987 for persons with severe hemophilia A was substantially greater than that for persons with severe hemophilia B (4.2 cases vs 1.9 cases per 100 persons).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126675      PMCID: PMC1349371          DOI: 10.2105/ajph.78.4.439

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  11 in total

1.  Exact and asymptotic methods for the combination of 2 times 2 tables.

Authors:  D G Thomas
Journal:  Comput Biomed Res       Date:  1975-10

2.  AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations.

Authors:  M V Ragni; G E Tegtmeier; J A Levy; L S Kaminsky; J H Lewis; J A Spero; F A Bontempo; C Handwerk-Leber; W L Bayer; D H Zimmerman
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

Review 3.  Factor IX complex.

Authors:  D L Aronson
Journal:  Semin Thromb Hemost       Date:  1979       Impact factor: 4.180

4.  Inactivation of HTLV-III/LAV during plasma fractionation.

Authors:  D Piszkiewicz; H Kingdom; R Apfelzweig; J S McDougal; S P Cort; J Andrews; J Hope; C D Cabridilla
Journal:  Lancet       Date:  1985-11-23       Impact factor: 79.321

5.  Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate.

Authors:  J J Goedert; M G Sarngadharan; M E Eyster; S H Weiss; A J Bodner; R C Gallo; W A Blattner
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

6.  Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.

Authors:  J K Kreiss; L W Kitchen; H E Prince; C K Kasper; A L Goldstein; P H Naylor; O Preble; J A Stewart; M Essex
Journal:  Am J Med       Date:  1986-03       Impact factor: 4.965

7.  Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends.

Authors:  R M Selik; E T Starcher; J W Curran
Journal:  AIDS       Date:  1987-09       Impact factor: 4.177

8.  Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.

Authors:  J S McDougal; L S Martin; S P Cort; M Mozen; C M Heldebrant; B L Evatt
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

9.  Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate.

Authors:  G F Gjerset; G McGrady; R B Counts; P J Martin; J Jason; S Kennedy; B Evatt; J A Hansen
Journal:  Blood       Date:  1985-09       Impact factor: 22.113

10.  Prevalence of HTLV-III antibody among New Mexico residents with hemophilia.

Authors:  H Waskin; K J Smith; T L Simon; T J Gribble; G J Mertz
Journal:  West J Med       Date:  1986-10
View more
  5 in total

1.  Survival analysis of hemophilia-associated AIDS cases in the US.

Authors:  J K Stehr-Green; R C Holman; M A Mahoney
Journal:  Am J Public Health       Date:  1989-07       Impact factor: 9.308

2.  Age and human immunodeficiency virus infection in persons with hemophilia in California.

Authors:  R C Holman; E D Gomperts; J M Jason; C F Abildgaard; M T Zelasky; B L Evatt
Journal:  Am J Public Health       Date:  1990-08       Impact factor: 9.308

3.  Prevalence of antibodies to hepatitis C virus (HCV) in haemophiliacs.

Authors:  W Schramm; M Roggendorf; F Rommel; R Kammerer; H Pohlmann; R Rasshofer; L Gürtler; F Deinhardt
Journal:  Blut       Date:  1989-10

4.  Wound infection rates after invasive procedures in HIV-1 seropositive versus HIV-1 seronegative hemophiliacs.

Authors:  J L Buehrer; D J Weber; A A Meyer; P R Becherer; W A Rutala; B Wilson; M L Smiley; G C White
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

Review 5.  Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV.

Authors:  P H Duesberg
Journal:  Genetica       Date:  1995       Impact factor: 1.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.